A single member of the Plasmodium falciparum var multigene family determines cytoadhesion to the placental receptor chondroitin sulphate A
Open accessThe DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
Abstract
In high-transmission regions, protective clinical immunity to Plasmodium falciparum develops during the early years of life, limiting serious complications of malaria in young children. Pregnant women are an exception and are especially susceptible to severe P. falciparum infections resulting from the massive adhesion of parasitized erythrocytes to chondroitin sulphate A (CSA) present on placental syncytiotrophoblasts. Epidemiological studies strongly support the feasibility of an intervention strategy to protect pregnant women from disease. However, different parasite molecules have been associated with adhesion to CSA. In this work, we show that disruption of the var2csa gene of P. falciparum results in the inability of parasites to recover the CSA-binding phenotype. This gene is a member of the var multigene family and was previously shown to be composed of domains that mediate binding to CSA. Our results show the central role of var2CSA in CSA adhesion and support var2CSA as a leading vaccine candidate aimed at protecting pregnant women and their fetuses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“P. falciparum IE adhesion to CSA is mediated by the large (~350 kD) protein called VAR2CSA”
From Designing a VAR2CSA-based vaccine to prevent placental malaria (2015) · cites this paper as [65]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“While gene knockout studies have demonstrated that VAR2CSA is required to maintain the CSA-binding phenotype [65]”
From Designing a VAR2CSA-based vaccine to prevent placental malaria (2015) · cites this paper as [65]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human Malaria Parasites in Continuous Culture
Trager, W., & Jensen, J. B. (1976) · Science · doi:10.1126/science.781840 · Cited by 7,844
Genome sequence of the human malaria parasite Plasmodium falciparum
Gardner, M. J., Hall, N., Fung, E., White, O., Berriman, M., Hyman, R. W., Carlton, J. M., Pain, A., Nelson, K. E., Bowman, S., et al. (2002) · Nature · doi:10.1038/nature01097 · Cited by 4,407
Su, X.-Z., Heatwole, V. M., Wertheimer, S. P., Guinet, F., Herrfeldt, J. A., Peterson, D. S., Ravetch, J. A., & Wellems, T. E. (1995) · Cell · doi:10.1016/0092-8674(95)90055-1 · Cited by 1,219
Adherence of Plasmodium falciparum to Chondroitin Sulfate A in the Human Placenta
Fried, M., & Duffy, P. E. (1996) · Science · doi:10.1126/science.272.5267.1502 · Cited by 1,108 · cited 2×
“Placental isolates are functionally distinct because they do not bind to CD36, but instead bind to CSA (Fried & Duffy, 1996) and, to some extent, to hyaluronic acid (Beeson et al, 2000).”
BackgroundAn analysis of malaria in pregnancy in Africa.
Brabin, B. J. (1983) · PubMed Central · Cited by 877
Salanti, A., Staalsoe, T., Lavstsen, T., Jensen, A. T. R., Sowa, M. P. K., Arnot, D. E., Hviid, L., & Theander, T. G. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03570.x · Cited by 702 · cited 2×
“Targeted disruption of the var2csa gene in FCR3 parasites It has been reported that var2csa is transcriptionally upregulated and expressed at the surface of CSA-binding parasites (Salanti et al, 2003, 2004; Gamain et al, 2005).”
BackgroundMaternal antibodies block malaria
Fried, M., Nosten, F., Brockman, A., Brabin, B. J., & Duffy, P. E. (1998) · Nature · doi:10.1038/27570 · Cited by 659
Rapid switching to multiple antigenic and adhesive phenotypes in malaria
Roberts, D. J., Craig, Berendt, A. R., Pinches, R., Nash, G., Marsh, K., & Newbold, C. I. (1992) · Nature · doi:10.1038/357689a0 · Cited by 619 · cited 1×
“Switching of var genes occurs in in vitrocultured parasites, and variants that are able to adhere to a large number of different host receptors have been isolated using receptor-specific panning assays (Roberts et al, 1992; Scherf et al, 1998).”
MethodScherf, A., Hernandez-Rivas, R., Buffet, P., Bottius, E., Benatar, C., Pouvelle, B., Gysin, J., & Lanzer, M. (1998) · The EMBO Journal · doi:10.1093/emboj/17.18.5418 · Cited by 610
Self-citationEvidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria
Salanti, A., Dahlbäck, M., Turner, L., Nielsen, M. A., Barfod, L., Magistrado, P., Jensen, A. T. R., Lavstsen, T., Ofori, M. F., Marsh, K., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041579 · Cited by 604
Cited by
Items 101–200 of 201
Pehrson, C., Mathiesen, L., Heno, K. K., Salanti, A., Resende, M., Dzikowski, R., Damm, P., Hansson, S. R., King, C. L., Schneider, H., et al. (2016) · Malaria Journal · doi:10.1186/s12936-016-1342-2 · Cited by 37
“VAR2CSA, a unique member of the PfEMP1 protein family, was discovered in 2003 [4], since then a large base of evidence supports the causal relationship between VAR2CSA and placental malaria [5–12].”
BackgroundFairhurst, R. M., & Wellems, T. E. (2006) · Current Opinion in Hematology · doi:10.1097/01.moh.0000219655.73162.42 · Cited by 31
Doritchamou, J., Bigey, P., Nielsen, M. A., Gnidehou, S., Ezinmegnon, S., Burgain, A., Massougbodji, A., Deloron, P., Salanti, A., & Ndam, N. T. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.07.072 · Cited by 29
“CSA is considered to be the principal or only placental receptor for IE [5], and selective disruption of the var2csa gene abrogates the binding ability of IE to CSA in vitro [6].”
BackgroundPreclinical immunogenicity and safety of the cGMP-grade placental malaria vaccine PRIMVAC
Chêne, A., Gangnard, S., Guadall, A., Ginisty, H., Leroy, O. Y., Havelange, N., Viebig, N. K., & Gamain, B. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.03.010 · Cited by 36
Self-citationAvril, M., Cartwright, M. M., Hathaway, M. J., & Smith, J. D. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-36 · Cited by 35
“Genetic disruption of var2CSA largely abolishes CSA-binding [14-16] suggesting it is the major var encoded product associated with placental sequestration.”
BackgroundBryant, J. M., Regnault, C., Scheidig‐Benatar, C., Baumgarten, S., Guizetti, J., & Scherf, A. (2017) · mBio · doi:10.1128/mbio.00729-17 · Cited by 31
Self-citationTomlinson, A., Semblat, J., Gamain, B., & Chêne, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.624126 · Cited by 39
Self-citationSevere malaria in children and pregnancy: an update and perspective
Milner, D. A., Montgomery, J. L., Seydel, K. B., & Rogerson, S. J. (2008) · Trends in Parasitology · doi:10.1016/j.pt.2008.09.001 · Cited by 31
Can any lessons be learned from the ambiguous glycan binding of PfEMP1 domains?
Dahlbäck, M., Nielsen, M. A., & Salanti, A. (2010) · Trends in Parasitology · doi:10.1016/j.pt.2010.02.002 · Cited by 32
Molecular Principles of Intrauterine Growth Restriction in Plasmodium Falciparum Infection
Seitz, J., Prieto, D. M. M., Fávaro, R. R., Schneider, H., & Markert, U. R. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00098 · Cited by 36
“While the disruption of the var2csa gene leads to the loss of CSA binding capacity (179, 186), no other highly regulated var genes are directly related to placental adhesion (187).”
BackgroundActivation and clustering of a Plasmodium falciparum var gene are affected by subtelomeric sequences
Duffy, M. F., Tang, J., Sumardy, F., Nguyen, H. H. T., Selvarajah, S. A., Josling, G. A., Day, K. P., Petter, M., & Brown, G. V. (2016) · FEBS Journal · doi:10.1111/febs.13967 · Cited by 28
Costa, F. T. M., Avril, M., Nogueira, P. A., & Gysin, J. (2006) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2006001200003 · Cited by 37
“var2CSA knockout parasites are unable to recover their initial CSA binding, even after repeated exposure to CSA (21,22).”
BackgroundSelf-citationHromatka, B. S., Ngeleza, S., Adibi, J. J., Niles, R. K., Tshefu, A. K., & Fisher, S. J. (2013) · Biology of Reproduction · doi:10.1095/biolreprod.112.106195 · Cited by 29
“Infected RBCs isolated from the maternal blood spaces of term placentas preferentially bind in vitro to chondroitin sulfate glycosaminoglycans (CS-GAGs) containing the chondroitin sulfate A (CS-A) motif [16, 17], and numerous groups have demonstrated that CS-A and VAR2CSA function as a receptor-ligand pair [18–20].”
BackgroundSingh, K., Gitti, R. K., Diouf, A., Zhou, H., Gowda, D. C., Miura, K., Ostazeski, S. A., Fairhurst, R. M., Garboczi, D. N., & Long, C. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.118612 · Cited by 26
Gangnard, S., Lewit-Bentley, A., Dechavanne, S., Srivastava, A., Amirat, F., Bentley, G. A., & Gamain, B. (2015) · Scientific Reports · doi:10.1038/srep14868 · Cited by 25
“Cys(10a) is the last canonical cysteine of DBL5ε, since it lacks Cys(11) and Cys(12) (which form cysteine bridges to Cys(10) and Cys(8), respectively).”
BackgroundSelf-citationBrolin, K. J. M., Persson, K. E. M., Wahlgren, M., Rogerson, S. J., & Chen, Q. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009230 · Cited by 24
“IRBC expressing the adhesin VAR2CSA adhere to the receptor CSA expressed by syncytiotrophoblast [4,5,6,7], and potentially enable the parasites to evade the immune system and successfully proliferate.”
BackgroundLopez-Perez, M., Larsen, M. D., Bayarri-Olmos, R., Ampomah, P., Stevenson, L., Arévalo-Herrera, M., Herrera, S., & Hviid, L. (2018) · Infection and Immunity · doi:10.1128/iai.00136-18 · Cited by 24
Knobs, Adhesion, and Severe Falciparum Malaria
Wiser, M. F. (2023) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed8070353 · Cited by 45
Pre-clinical and clinical development of the first placental malaria vaccine
Pehrson, C., Salanti, A., Theander, T. G., & Nielsen, M. A. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1322512 · Cited by 34
“Disruption of the var2csa gene prevents infected erythrocytes from binding to CSA and the parasites lose the placental phenotype [41,42].”
BackgroundSenga, E. L., Loscertales, M., Makwakwa, K., Liomba, G. N., Dzamalala, C. P., Kazembe, P. N., & Brabin, B. J. (2007) · Malaria Journal · doi:10.1186/1475-2875-6-102 · Cited by 26
Developing vaccines to prevent malaria in pregnant women
Ndam, N. T., & Deloron, P. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1049595 · Cited by 30
“Erythrocytes infected by var2csa knockout parasites have reduced the ability to bind to the placenta, demonstrating that var2csa is the primary var gene responsible for the CSA-binding phenotype [42,43].”
BackgroundNacer, A., Roux, E., Pomel, S., Scheidig‐Benatar, C., Sakamoto, H., Lafont, F., Scherf, A., & Mattei, D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029039 · Cited by 22
“For Southern blotting genomic DNA was digested with EcoRI and SpeI (BioLabs), and processed as described [29].”
MethodSelf-citationObiakor, H., Avril, M., MacDonald, N. J., Srinivasan, P., Reiter, K., Anderson, C., Holmes, K. L., Fried, M., Duffy, P. E., Smith, J. D., et al. (2013) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00638-12 · Cited by 22
“Gene disruption has been used to show that var2csa is the primary var gene responsible for CSA binding (11, 15, 17).”
BackgroundMethodPlasmodium falciparumduring pregnancy: a puzzling parasite tissue adhesion tropism
Nunes, M. C., & Scherf, A. (2007) · Parasitology · doi:10.1017/s0031182007000133 · Cited by 24
“Available evidence from different laboratories suggests that a particular var gene, var2CSA, is selectively expressed during placental infection and in IEs selected to adhere to CSA in vitro (Gamain et al. 2005; Salanti et al. 2003; Viebig et al. 2005).”
BackgroundSelf-citationINFECTIONS AND INFLAMMATORY LESIONS OF THE PLACENTA
Fox, H., & Sebire, N. J. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-2592-4.50016-3 · Cited by 23
Dorin, D., Tétard, M., Claës, A., Semblat, J., Dechavanne, S., Fourati, Z., Hamelin, R., Armand, F., Matesic, G., Nunes-Silva, S., et al. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000308 · Cited by 24
“Indeed, var2csa is the only var gene expressed in CSA-binding–selected IEs [16–18], and Δ var2csa mutant clones lose the CSA-binding phenotype [19,20].”
Self-citationTétard, M., Milet, J., Dechavanne, S., Fiévet, N., Dorin, D., Élion, J., Fairhurst, R. M., Deloron, P., Ndam, N. T., & Gamain, B. (2017) · Scientific Reports · doi:10.1038/s41598-017-01495-9 · Cited by 20
Self-citationKane, E. G., & Taylor-Robinson, A. W. (2011) · Malaria Research and Treatment · doi:10.4061/2011/764845 · Cited by 22
“The var2csa gene is required for pRBC to adhere to CSA [86]”
BackgroundNacer, A., Claës, A., Roberts, A., Scheidig‐Benatar, C., Sakamoto, H., Ghorbal, M., Lopez-Rubio, J.-J., & Mattei, D. (2015) · Cellular Microbiology · doi:10.1111/cmi.12430 · Cited by 24
“Specific subsets of var genes are associated with IE sequestration to particular tissues in the placenta (Viebig et al., 2005) or the brain in cerebral malaria patients as determined by post-mortem studies (Tembo et al.”
BackgroundMethodYosaatmadja, F., Andrews, K. T., Duffy, M. F., Brown, G. V., Beeson, J. G., & Rogerson, S. J. (2008) · Malaria Journal · doi:10.1186/1475-2875-7-51 · Cited by 21
“Following genetic disruption of var2csa there is little or no binding to CSA [16,17].”
Malaria: New Vaccines for Old?
Waters, A. P. (2006) · Cell · doi:10.1016/j.cell.2006.02.011 · Cited by 26
Gangnard, S., Badaut, C., Ramboarina, S., Baron, B., Ramdani, T., Gamain, B., Deloron, P., Lewit‐Bentley, A., & Bentley, G. A. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.02.014 · Cited by 22
Self-citationWang, W., Wang, Z., Yang, X., Gao, Y., Zhang, X., Wang, W., Zhao, L., zhang, J., Jing, Q., Xu, Q., et al. (2021) · Cell Discovery · doi:10.1038/s41421-021-00324-8 · Cited by 19
Higgins, M. K. (2008) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309108004211 · Cited by 16
Nunes-Silva, S., Gangnard, S., Vidal, M., Vuchelen, A., Dechavanne, S., Chan, S., Pardon, E., Steyaert, J., Ramboarina, S., Chêne, A., et al. (2014) · Scientific Reports · doi:10.1038/srep07373 · Cited by 15
Self-citationDoritchamou, J., Sossou-tchatcha, S., Cottrell, G., Moussiliou, A., Hounton Houngbeme, C., Massougbodji, A., Deloron, P., & Ndam, N. T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098577 · Cited by 16
“Although it has been suggested that other molecules (hyaluronic acid and non-immune globulins) may participate in the adhesion of IE in the placenta [20–22], several lines of evidence indicate that CSA is the most important receptor involved [2,3,17,23–28].”
BackgroundBadaut, C., Bertin, G. I., Rustico, T., Fiévet, N., Massougbodji, A., Gaye, A., & Deloron, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011276 · Cited by 20
“falciparum IRBC and parasites isolated from infected placentas [6,7,8,9,10].”
BackgroundGill, J., Chitnis, C. E., & Sharma, A. K. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-67 · Cited by 18
“Significantly, var2CSA knock-out parasites revealed that no other parasite ligand can promote adhesion to CSA [6].”
BackgroundTreatment and prevention of malaria in pregnancy: opportunities and challenges
Rogerson, S. J., & Menéndez, C. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.4.687 · Cited by 16
Guinovart, C., & Alonso, P. L. (2007) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.276 · Cited by 18
Structural insights into chondroitin sulfate binding in pregnancy-associated malaria
Khunrae, P., & Higgins, M. K. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381337 · Cited by 18
Recker, M., Arinaminpathy, N., & Buckee, C. O. (2008) · Malaria Journal · doi:10.1186/1475-2875-7-18 · Cited by 14
“For example, if there exists a small genetically isolated partition that can be associated with severe disease, this subset would be a good vaccine candidate in much the same way that var2CSA, whose expression has been associated with the phenomenon of pregnancy associated malaria [39,40], is being used as the basis f…”
Hviid, L. (2007) · Microbes and Infection · doi:10.1016/j.micinf.2007.02.008 · Cited by 16
Pregnancy-associated Malaria, Challenges and Prospects in Sub-Saharan Africa
Aguzie, I. O. N. (2018) · Clinics in Mother and Child Health · doi:10.4172/2090-7214.1000282 · Cited by 13
“falciparum-infected erythrocyte to chondroitin sulphate proteoglycans in the placental intervillous space defines morbidity [44-46].”
BackgroundTalundzic, E., Shah, S., Fawole, O., Owino, S. O., Moore, J. M., & Peterson, D. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031565 · Cited by 14
“During pregnancy, expression of a single member of the var gene family, var2csa, mediates binding to a form of chondroitin sulfate A (CSA) unique to the placenta [3,4,5,6,7].”
BackgroundSaveria, T., Oleinikov, A. V., Wiliamson, K., Chaturvedi, R., Lograsso, J., Keitany, G. J., Fried, M., & Duffy, P. E. (2013) · Infection and Immunity · doi:10.1128/iai.00978-12 · Cited by 15
“Importantly, parasites engineered to lose the VAR2CSA gene lose the ability to adhere to CSA (17, 18).”
BackgroundLooker, O., Dans, M. G., Bullen, H. E., Sleebs, B. E., Crabb, B. S., & Gilson, P. R. (2022) · Traffic · doi:10.1111/tra.12862 · Cited by 14
“Parasite cytoadhesion in the placenta is mediated by the PfEMP1 variant VAR2CSA which is specifically responsible for CSA binding.(78,79) Following a 5-h drug treatment, CS2 parasites (expressing VAR2CSA) at 20–25 hpi were passaged through a CSA-lined microchannel (Figure 8A).”
MethodBadaut, C., Faure, G., Ndam, N. T., Bertin, G. I., Chaffotte, A. F., Khattab, A., Klinkert, M., Deloron, P., & Bentley, G. A. (2006) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2006.10.010 · Cited by 12
Pregnancy malaria: cryptic disease, apparent solution
Duffy, P. E., & Fried, M. (2011) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762011000900008 · Cited by 12
“Parasites engineered with a deletion of the var2csa gene lose the ability to adhere to CSA (Viebig et al. 2005, Duffy et al. 2006).”
Backgroundvar Gene Expression and Human Plasmodium pathogenesis
Tembo, D. L., & Montgomery, J. L. (2010) · Future Microbiology · doi:10.2217/fmb.10.33 · Cited by 14
A Greedy Promoter Controls Malarial Var-iations
Scherf, A. (2006) · Cell · doi:10.1016/j.cell.2006.01.004 · Cited by 11
Self-citationPfEMP1-Specific Immunoglobulin G Reactivity Among Beninese Pregnant Women With Sickle Cell Trait
Lopez-Perez, M., Viwami, F., Seidu, Z., Jensen, A. T. R., Doritchamou, J., Ndam, N. T., & Hviid, L. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab527 · Cited by 11
“IT4VAR04 is a VAR2CSA-type PfEMP1 protein involved in chondroitin sulfate A (CSA)-binding, causing placental malaria [9, 10].”
BackgroundInfluentialHow does Plasmodium falciparum stick to CSA? Let's see in the crystal
Bentley, G. A., & Gamain, B. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb0908-895 · Cited by 11
Self-citationThe glycobiology of plasmodium falciparum: New approaches and recent advances
Izquierdo, L. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108178 · Cited by 7
Assessing the burden of pregnancy-associated malaria under changing transmission settings
Recker, M., Bouma, M. J., Bamford, P., Gupta, S., & Dobson, A. P. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-245 · Cited by 11
“Malarial infections during pregnancy in these regions are usually associated with placental sequestration of parasites adhering to glycosaminoglycan chondroitin sulphate A (CSA) through the expression of var2csa [8-11], a member of the var gene family which encodes the immunodominant surface antigens and virulence fac…”
BackgroundKeitany, G. J., Jenkins, B. J., Obiakor, H., Shaji, D., Muehlenbachs, A., Semblat, J., Gamain, B., Doritchamou, J., Desai, S. A., MacDonald, N. J., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab550 · Cited by 12
Self-citationWheat germ cell-free technology for accelerating the malaria vaccine research
Takeo, S., Arumugam, T. U., Torii, M., & Tsuboi, T. (2009) · Expert Opinion on Drug Discovery · doi:10.1517/17460440903369813 · Cited by 8
“A program to develop a vaccine based on VAR2CSA is underway [17,34-38].”
BackgroundFastman, Y., Assaraf, S., Rose, M., Milrot, E., Basore, K., Arasu, B. S., Desai, S. A., Elbaum, M., & Dzikowski, R. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky178 · Cited by 8
“CSA is an abundant glycosaminoglycan expressed in the placental intervillous space and is bound by a specific PfEMP1 variant named VAR2CSA (9).”
BackgroundInfluentialGangnard, S., Chêne, A., Dechavanne, S., Srivastava, A., Avril, M., Smith, J. D., & Gamain, B. (2019) · Scientific Reports · doi:10.1038/s41598-019-53334-8 · Cited by 8
Self-citationHow specific is Plasmodium falciparum adherence to chondroitin 4-sulfate?
Goel, S., & Gowda, D. C. (2011) · Trends in Parasitology · doi:10.1016/j.pt.2011.03.005 · Cited by 10
Mahamar, A., Traoré, M., Swihart, B., Attaher, O., Diarra, B. S., Gaoussou, S., Issiaka, D., Barry, A., Sidibé, Y., Dicko, Y. T., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1330962 · Cited by 8
Dorin, D., Semblat, J., Hamelin, R., Srivastava, A., Tétard, M., Matesic, G., Doerig, C., & Gamain, B. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1012861 · Cited by 8
Self-citationFrank, V., Chushkin, Y., Fröhlich, B., Abuillan, W., Rieger, H., Becker, A. S., Yamamoto, A., Rossetti, F. F., Kaufmann, S., Lanzer, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-14586-4 · Cited by 7
Self-citationChauvet, M., Tétard, M., Cottrell, G., Aussenac, F., Brossier, E., Denoyel, L., Hanny, M., Lohezic, M., Milet, J., Ndam, N. T., et al. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz156 · Cited by 8
“Adhesion of iRBCs in the placenta is mediated by a single var gene, VAR2CSA [4, 5], the PfEMP1 variant that interacts with chondroitin sulfate A (CSA) on syncytiotrophoblasts [6–8].”
BackgroundSelf-citationAntigenic Variation, Adherence, and Virulence in Malaria
Smith, J. D., & Deitsch, K. (2012) · Wiley eBooks · doi:10.1002/9781118308165.ch18 · Cited by 6
Morley, L. C. (2012) · The Open Vaccine Journal · doi:10.2174/1875035401205010008 · Cited by 8
“, [45] generated a mutant parasite isolate in which the var2CSA DBL4- domain was replaced with an inactive cassette.”
Djontu, J. C., Lloyd, Y. M., Megnekou, R., Seumko’o, R. M. N., Salanti, A., Taylor, D. W., & Leke, R. G. F. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237671 · Cited by 6
“Previous studies reported that parasites with a VAR2CSA knock-out gene irreversibly lose the ability to adhere to CSA [11], and that Ab to VAR2CSA inhibit IE binding to CSA in vitro [12, 13].”
BackgroundWei, L., Xu, Y., Du, M., Fan, Y., Zou, R., Xu, X., Zhang, Q., Zhang, Y., Wang, W., & Li, F. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.120508 · Cited by 7
In silico guided reconstruction and analysis of ICAM-1-binding var genes from Plasmodium falciparum
Carrington, E., Otto, T. D., Szestak, T., Lennartz, F., Higgins, M. K., Newbold, C., & Craig, A. G. (2018) · Scientific Reports · doi:10.1038/s41598-018-21591-8 · Cited by 6
Hviid, L. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070246 · Cited by 6
“Reassuringly, VAR2CSA contains CSA-binding domains, and parasites lacking the gene encoding it due to knockout can no longer be selected for adhesion to CSA.(18,19) Does this mean that the solution to the puzzle of PAM lies in careful dissection of the interaction between CSA and VAR2CSA and finding ways of blocking i…”
BackgroundInfluentialNetwork Models for Malaria: Antigens, Dynamics, and Evolution Over Space and Time
Childs, L. M., & Larremore, D. B. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11512-0 · Cited by 4
Basic Structure of a Placental Villus
Burton, G. J. (2021) · Springer eBooks · doi:10.1007/978-3-030-84725-8_6 · Cited by 9
Adams, Y., Schwartz‐Albiez, R., McCarthy, J. S., & Andrews, K. T. (2007) · Parasitology Research · doi:10.1007/s00436-007-0473-3 · Cited by 4
“P. falciparum lines 3D7 (Walliker et al. 1987), CS2 (Rogerson et al. 1995) and PH1 (Chen et al. 2003) were cultured in vitro as previously described ( Trager and Jensen 1976; Jensen 1978).”
MethodDiouf, I., Tine, R. C. K., Ndiaye, J. L., Sylla, K., Faye, B. F., Mengue, M. L., Faye, O., Dieng, Y., Gaye, A., & Gaye, O. (2011) · Bulletin de la Société de pathologie exotique · doi:10.1007/s13149-011-0153-5 · Cited by 4
“[26,27,35].”
Dube, Y., Hasang, W., Teo, A., Madanitsa, M., Nielsen, M. A., ter Kuile, F. O., Aitken, E. H., & Rogerson, S. J. (2025) · Journal of Immunological Methods · doi:10.1016/j.jim.2025.114003 · Cited by 5
Doritchamou, J., Nielsen, M. A., Chêne, A., Viebig, N. K., Lambert, L., Sander, A. F., Semblat, J., Hundt, S., Orr-Gonzalez, S., Janitzek, C. M., et al. (2023) · Lab Animal · doi:10.1038/s41684-023-01274-2 · Cited by 4
Self-citationLawton, J. G., Zhou, A. E., Stucke, E. M., Takala‐Harrison, S., da Silva, J. C. F., & Travassos, M. A. (2025) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2025.105725 · Cited by 4
Extraction and Immunoprecipitation of VAR2CSA, the PfEMP1 Associated with Placental Malaria
Gamain, B., & Dorin, D. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2189-9_19 · Cited by 3
Self-citationTanaka, M., & Lanzer, M. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2189-9_45 · Cited by 2
Self-citationA Silicon Rhodamine‐fused Glibenclamide to Label and Detect Malaria‐infected Red Blood Cells
Bastl, C., Close, C. M., Holtz, I., Gatin‐Fraudet, B., Eis, M., Werum, M., Konrad, S., Kneller, L., Roßmann, K., Huhn, C., et al. (2025) · ChemBioChem · doi:10.1002/cbic.202400628 · Cited by 2
Georgiev, V. S. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-297-1_20 · Cited by 1
Diffendall, G., Millot, P., Chen, P. B., Fogang, B., Dorin, D., Aprahamian, F., Durand, S., Gamain, B., Claessens, A., & Scherf, A. (2026) · Nature Microbiology · doi:10.1038/s41564-026-02268-9 · Cited by 1
Self-citationDevelopment of a recombinant protein vaccine against Plasmodium falciparum malaria
Ahuja, S. P. (2006) · Figshare · Cited by 1
SURFACE ANTIGENS AND VIRULENCE IN PLASMODIUM FALCIPARUM MALARIA
Normark, J. (2008) · Figshare · Cited by 1
Nilsson, S. (2011) · Figshare · Cited by 2
Blomqvist, K. (2011) · Figshare
Hviid, L., & Theander, T. G. (2007) · International Journal of Biotechnology · doi:10.1504/ijbt.2007.014249
Ei, H., & Babikir, H. (2010)
Goyal, S. C., Meghwal, B., Jain, B., & Mehta, S. (2016) · International Journal of Biomedical Research · doi:10.7439/ijbr.v7i7.3425
“Currently, there are two major hypotheses explaining CM etiology, these are the mechanical and the humoral hypotheses.[4] Activation of microglia and astrocytes in the brain might cause the cerebral symptoms by excitotoxic mechanisms which may be one of the causes of cerebral symptoms.”
BackgroundAnalysis of Total HLA-G Levels and Its Isoforms in Placental Malaria
Karau, G. M. (2012)
Mitran, C. J. (2021) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-qs9p-em57
Rovira-Vallbona, E. (2011) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Gonçalves, B. P., Fried, M., & Duffy, P. E. (2016) · Wiley eBooks · doi:10.1002/9781118493816.ch16 · Cited by 3
RNAseq of Infected Erythrocyte Surface Antigen-Encoding Genes
Nguyen, H. H. T., Azizan, S., Yeoh, L. M., Tang, J., & Duffy, M. F. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2189-9_15
Molecular Docking and Analysis of some Ligands on Var2csA Target
Okeke, I. (2022) · Journal of Health Medicine and Clinical Studies · doi:10.58425/jhmcs.v1i1.84 · Cited by 1
Taurine is a Natural Host Cytoadhesion Inhibitor in Asymptomatic Malaria CasesPreprint
Diffendall, G., Millot, P., Chen, P. B., Fogang, B., Dorin, D., Aprahamian, F., Durand, S., Gamain, B., Claessens, A., & Scherf, A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.06.663375
Self-citationExploring the Potential of miRNA-92a-3p as Lead for Sequence-Based Therapies for Malaria
Prabhu, S. R., Paul, S., Umakanth, S., Hande, M., Saadi, A. V., Gupta, H., & Satyamoorthy, K. (2025) · Acta Parasitologica · doi:10.1007/s11686-025-01117-9
“This finding is suggestive of the ability of mutated strains to switch their expression to that of other variants upon disruption [32, 33].”
Développement de thérapies adjuvantes associées à l’anti-cytoadhérence.
Patil, P. (2011) · theses.fr (ABES) · doi:10.70675/1c21a6eaz0cf8z454fz9b42z330bc52a95ea
Metadata
- Authors
- Viebig, N. K., Gamain, B., Scheidig, C., Lépolard, C., Przyborski, J., Lanzer, M., Gysin, J., & Scherf, A.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Université de la Méditerranée Aix-Marseille II (FR)
- University Hospital Heidelberg (DE)
- Corresponding author
- Scherf, Artur
- Venue
- The EMBO Reports
- Published
- 2005-08-01
- Volume
- 6
- Issue
- 8
- Pages
- 775-781
- ISSN
- 1469-221X (ISSN-L)
- 1469-3178
- PMC
- PMC1369142
- OpenAlex
- W2155425270
- Cited by
- 201
- References
- 37
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 1 · 2023: 4 · 2022: 7 · 2021: 8 · 2020: 3 · 2019: 8 · 2018: 6 · 2017: 5 · 2016: 8 · 2015: 8 · 2014: 4 · 2013: 7 · 2012: 8
- FWCI
- 22.98
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- EMBO Reports (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bill and Melinda Gates Foundation
- European Commission
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Keywords
- Plasmodium falciparum, VAR2CSA, chondroitin sulfate A, cytoadhesion, placental malaria, syncytiotrophoblast, vaccine candidate, pregnancy protection, parasite surface proteins
- MeSH terms
- Animals, Antibodies, Protozoan, Antigenic Variation, Cell Adhesion, Chondroitin Sulfates, Cloning, Molecular, Crossing Over, Genetic, Exons, Female, Multigene Family, Humans, Models, Biological, Models, Genetic, Mutation, Phenotype, Placenta, Plasmids, Plasmodium falciparum, Pregnancy, Protein Binding, RNA, Time Factors, Trophoblasts, Blotting, Southern, Blotting, Northern, Pregnancy Complications, Parasitic, Protozoan Proteins, Genome, Malaria, Falciparum, Genome, Protozoan, CD36 Antigens
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.